(Q34158517)

31 July 2017

title

T cells require TRAIL for optimal graft-versus-tumor activity (English)

1 reference

31 July 2017

12

Hideo Yagita

1 reference

Marcel R.M. van den Brink

31 July 2017

object named as

Marcel R M van den Brink

15

1 reference

ORCID Public Data File 2021

Henning Walczak

object named as

Henning Walczak

13

1 reference

ORCID Public Data File 2021

author name string

Cornelius Schmaltz

1

1 reference

31 July 2017

Onder Alpdogan

2

1 reference

31 July 2017

Barry J Kappel

3

1 reference

31 July 2017

Stephanie J Muriglan

4

1 reference

31 July 2017

Jimmy A Rotolo

5

1 reference

31 July 2017

Jennifer Ongchin

6

1 reference

31 July 2017

Lucy M Willis

7

1 reference

31 July 2017

Andrew S Greenberg

8

1 reference

31 July 2017

Jeffrey M Eng

9

1 reference

31 July 2017

James M Crawford

10

1 reference

31 July 2017

George F Murphy

11

1 reference

31 July 2017

Jacques J Peschon

14

1 reference

31 July 2017

language of work or name

English

0 references

publication date

11 November 2002

1 reference

31 July 2017

1 reference

31 July 2017

volume

8

1 reference

31 July 2017

issue

12

1 reference

31 July 2017

page(s)

1433-1437

1 reference

Identification and characterization of a new member of the TNF family that induces apoptosis

31 July 2017

cites work

1 reference

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

21 January 2018

1 reference

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

21 January 2018

1 reference

Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs

21 January 2018

1 reference

Haematopoietic cell transplantation as immunotherapy

21 January 2018

1 reference

Cytotoxic T cells deficient in both functional fas ligand and perforin show residual cytolytic activity yet lose their capacity to induce lethal acute graft-versus-host disease

21 January 2018

1 reference

TRAIL/Apo-2-ligand-induced apoptosis in human T cells.

21 January 2018

1 reference

Surface expression of TRAIL/Apo-2 ligand in activated mouse T and B cells

21 January 2018

1 reference

Safety and antitumor activity of recombinant soluble Apo2 ligand

21 January 2018

1 reference

Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity.

21 January 2018

1 reference

Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice

21 January 2018

1 reference

Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice

21 January 2018

1 reference

Cutaneous acute graft-versus-host disease to minor histocompatibility antigens in a murine model: histologic analysis and correlation to clinical disease

21 January 2018

1 reference

Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells

21 January 2018

1 reference

7 January 2021

Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect

1 reference

7 January 2021

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

1 reference

7 January 2021

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

1 reference

7 January 2021

Fas-deficient lpr mice are more susceptible to graft-versus-host disease

1 reference

7 January 2021

Long-term T cell fitness and proliferation is driven by AMPK-dependent regulation of reactive oxygen species

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM1202-797

1 reference

31 July 2017

1 reference